TREATMENT OF METASTIC BREAST CANCER
The present invention concerns treatment of previously untreated HER2-positive metastatic breast cancer with a combination of a growth inhibitory HER2 antibody, a HER2 dimerization inhibitor antibody and a taxane. In particular, the invention concerns the treatment of HER2-positiv metastatic breast...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
18.02.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!